The medication semaglutide (Wegovy) received FDA approval for treatment of obesity in 2021. More common prescription weight loss drugs which have been in use longer include: Liraglutide, bupropion/naltrexone (contrave) , phentermine- multiple doses , Phentermine-Topiramate combination (Qysmia), and other GLP-1 agonist or GIP/GLP-1 agonists. Newer drugs will be revealed in 2023.
We will customize a medication program that suits your needs. Every medication has a mechanism for its help with weight loss. In addition, they all have various side-effect profiles.
                        GLP-1 Agonists
GLP-1 Agonists include Liraglutide (Saxenda), Dulaglutide (Trulicity), Semaglutide (Wegovy),Exenatide extended release (Bydureon bcise) (weekly), Exenatide (Byetta) (twice daily). GLP-1RAs work by reducing the appetite and feelings of hunger, slowing the release of food from the stomach, and increasing feelings of fullness after eating
GLP-1/GIP
Tirzepatide (Mounjaro) which is approved for use in T2DM can also help you lose weight with dual actions similar to GLP1 Agonists.
           WHAT ARE COMPOUNDED GLP-1 MEDICATIONS?
Because of the shortage in semaglutide and other GLP-1s we have sourced specialty pharmacies that can make those medications for off-label weight loss use.
